Health Sciences Acquisitions Corp 2 OBIO
Health Sciences Acquisitions Corp 2 FY 2021: net loss $379K; diluted EPS −$0.02
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001213900-22-016849
- Document
- 10-K
- Exhibit 4.3
- Description of securities
Key figures from this report
These are the numbers Health Sciences Acquisitions Corp 2 reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Net income−$379KNo year-earlier figure tagged10-K income statement, on EDGAR
- Diluted EPS−$0.02No year-earlier figure tagged10-K income statement, on EDGAR
- Cash and cash equivalents$1.8M−13% from $2.0M in FY 202010-K balance sheet, on EDGAR
- Cash from operations−$272KNo year-earlier figure tagged10-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Myomo MYO public float $62M, Jun 30, 2025
- Edap TMS EDAP public float $62M, Jun 30, 2025
- InspireMD NSPR public float $61M, Jun 30, 2025
- Cytosorbents CTSO public float $61M, Jun 30, 2025
- Pro Dex PDEX public float $68M, Dec 31, 2025